Corteva vs Leidos
Side-by-side comparison of AI visibility scores, market position, and capabilities
Indianapolis agricultural seeds and crop protection (NYSE: CTVA) $17.2B FY2024 revenue; Pioneer Hi-Bred seeds, Enlist weed system, Qrome corn traits, competing with Bayer Crop Science and Syngenta.
About
Corteva, Inc. is an Indianapolis, Indiana-based agricultural science company — publicly traded on the New York Stock Exchange (NYSE: CTVA) as an S&P 500 Materials component — developing and selling seeds (Pioneer brand corn, soybean, sunflower, and vegetable seeds) and crop protection products (herbicides, insecticides, fungicides under Enlist, Instinct, Zorvec, and other brands) to farmers across 140 countries through approximately 22,000 employees. Corteva was spun off from DowDuPont in June 2019 as the agricultural science component of the DowDuPont three-way breakup (materials science → Dow Inc., specialty products → DuPont de Nemours, agriculture → Corteva), combining the Pioneer Hi-Bred seed genetics legacy (acquired by DuPont in 1999 for $9.4 billion) with the Dow AgroSciences crop protection portfolio. In fiscal year 2024, Corteva reported revenues of $17.2 billion, with the Seed segment (corn, soybean, and specialty crop seeds) generating $9.3 billion and the Crop Protection segment (pesticides, herbicides, fungicides) generating $7.9 billion — though crop protection faced market headwinds from generic agrochemical price competition and grower inventory destocking as global commodity crop prices fell from 2022-2023 peaks. CEO Chuck Magro's strategy focuses on driving pricing power through genetic trait performance (Corteva's Qrome corn trait technology delivering 5-10 bushel/acre yield advantage driving premium seed pricing) and the Enlist weed control system (herbicide-tolerant soybeans paired with Enlist Duo herbicide through a closed IP system that bundles herbicide and trait royalty revenue).
Reston VA defense intelligence and government IT (NYSE: LDOS) $16.7B FY2024 revenue (+8%); NSA/DoD classified IT, VA EHRM $10B+ EHR modernization, Smiths Detection, competing with SAIC and Booz Allen.
About
Leidos Holdings, Inc. is a Reston, Virginia-based defense, intelligence, and civil government IT services company — publicly traded on the New York Stock Exchange (NYSE: LDOS) as an S&P 500 Industrials component — providing national security solutions (IT services for US intelligence community, Department of Defense analytics, cybersecurity), health and civil government services (VA electronic health records, HHS IT systems, FAA air traffic control modernization), and commercial services through approximately 47,000 employees. In fiscal year 2024, Leidos reported revenues of $16.7 billion (+8% year-over-year), with the National Security & Digital segment generating the majority of revenue from classified intelligence community IT programs and Department of Defense cybersecurity and analytics contracts, while Health & Civil generated revenue from the Leidos Digital Modernization contract for the Department of Veterans Affairs electronic health records (replacing VistA legacy EHR with Oracle Cerner's Millennium platform) — a 10-year, $10+ billion program that was simultaneously Leidos's largest contract and largest program execution challenge. CEO Tom Bell (joined 2023, previously from Rolls-Royce North America) has focused Leidos on transitioning from IT services to technology-enabled solutions: augmenting traditional government IT labor with proprietary software products (Leidos AI/ML platforms, cloud migration tools, cybersecurity automation) that generate higher margins than staff augmentation. The $1.65 billion acquisition of the security detection and automation business of Smiths Group (X-ray security screening equipment — baggage scanners for TSA checkpoints) in 2021 expanded Leidos into physical security hardware and detection systems for government and commercial airports.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.